CETRORELIX ACETATE FOR INJECTION

CETRORELIX ACETATE FOR INJECTION was reported 63 times

CETRORELIX ACETATE FOR INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD OESTROGEN INCREASED 14 0.0238
1 RESPIRATORY TRACT MALFORMATION 1 0.0075
2 ENTEROBACTER PNEUMONIA 1 0.0064
3 OVARIAN HYPERSTIMULATION SYNDROME 11 0.0047
4 VASCULAR STENOSIS 1 0.0029
5 THREATENED LABOUR 1 0.0023
6 URINARY TRACT PAIN 1 0.0020
7 DRUG LEVEL DECREASED 20 0.0020
8 RUPTURED ECTOPIC PREGNANCY 1 0.0013
9 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
10 TWIN PREGNANCY 1 0.0012
11 ABSCESS DRAINAGE 1 0.0012
12 CEREBRAL VENOUS THROMBOSIS 1 0.0006
13 PRODUCT LEAKAGE 2 0.0004
14 ECTOPIC PREGNANCY 1 0.0003
15 HEPATIC CYST 1 0.0003
16 HYPOMANIA 1 0.0003
17 VULVOVAGINAL DISCOMFORT 1 0.0002
18 GESTATIONAL DIABETES 1 0.0002
19 ENTEROCOCCAL INFECTION 1 0.0002
20 KLEBSIELLA INFECTION 1 0.0002
21 CATATONIA 1 0.0002
22 NYSTAGMUS 1 0.0002
23 PREMATURE LABOUR 1 0.0002
24 CAESAREAN SECTION 2 0.0002
25 OLIGURIA 1 0.0002
26 NEPHROTIC SYNDROME 1 0.0001
27 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
28 ORAL DISORDER 1 0.0001
29 BLINDNESS TRANSIENT 1 0.0001
30 PULMONARY HAEMORRHAGE 1 0.0001
31 DRUG INTERACTION 20 0.0001
32 RENAL CYST 1 0.0001
33 PELVIC PAIN 2 0.0001
34 ATELECTASIS 1 0.0001
35 HYPOTONIA 1 0.0001
36 ABORTION SPONTANEOUS 4 0.0001
37 NERVE INJURY 1 0.0001
38 GENERALISED OEDEMA 1 0.0001
39 ANKYLOSING SPONDYLITIS 1 0.0001
40 DEVICE BREAKAGE 3 0.0001
41 PARAESTHESIA ORAL 1 0.0001
42 CONDITION AGGRAVATED 21 0.0001
43 MANIA 1 0.0001
44 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
45 DEVICE DEFECTIVE 1 0.0001
46 DEVICE USE ISSUE 1 0.0001
47 PULMONARY FIBROSIS 1 0.0001
48 PREGNANCY 1 0.0000
49 ABDOMINAL DISTENSION 5 0.0000
50 PRODUCT DISPENSING ERROR 1 0.0000
51 TRANSAMINASES INCREASED 1 0.0000
52 CEREBRAL INFARCTION 1 0.0000
53 HAEMOPTYSIS 1 0.0000
54 ASCITES 1 0.0000
55 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
56 PLEURAL EFFUSION 2 0.0000
57 INJECTION SITE RASH 1 0.0000
58 DELIRIUM 1 0.0000
59 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
60 DYSARTHRIA 1 0.0000
61 SEIZURE 3 0.0000
62 ANGIOEDEMA 1 0.0000
63 SWELLING 2 0.0000
64 DISEASE RECURRENCE 1 0.0000
65 TREATMENT NONCOMPLIANCE 1 0.0000
66 OXYGEN SATURATION DECREASED 1 0.0000
67 LETHARGY 1 0.0000
68 PRODUCT SUBSTITUTION ISSUE 1 0.0000
69 VERTIGO 1 0.0000
70 EXPOSURE DURING PREGNANCY 1 0.0000
71 DRUG INEFFECTIVE 18 0.0000
72 ABDOMINAL PAIN 3 0.0000
73 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
74 INFLUENZA LIKE ILLNESS 1 0.0000
75 DEVICE ISSUE 1 0.0000
76 NO ADVERSE EVENT 2 0.0000
77 OFF LABEL USE 9 0.0000
78 PRODUCT DOSE OMISSION ISSUE 3 0.0000
79 CHEST DISCOMFORT 1 0.0000
80 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
81 HAEMORRHAGE 1 0.0000
82 PLATELET COUNT DECREASED 1 0.0000
83 ASTHMA 1 0.0000
84 MUSCULAR WEAKNESS 1 0.0000
85 INJECTION SITE ERYTHEMA 1 0.0000
86 PSORIASIS 1 0.0000
87 HYPOAESTHESIA 1 0.0000
88 VOMITING 3 0.0000
89 TREMOR 1 0.0000
90 URTICARIA 1 0.0000
91 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
92 NASOPHARYNGITIS 1 0.0000
93 HYPERSENSITIVITY 1 0.0000
94 ANAEMIA 1 0.0000
95 GAIT DISTURBANCE 1 0.0000
96 ABDOMINAL PAIN UPPER 1 0.0000
97 MALAISE 2 0.0000
98 BACK PAIN 1 0.0000
99 COUGH 1 0.0000
100 INJECTION SITE PAIN 1 0.0000
101 NAUSEA 2 0.0000
102 ARTHRALGIA 1 0.0000
103 DIZZINESS 1 0.0000
104 DYSPNOEA 1 0.0000
105 DIARRHOEA 1 0.0000